NCT06256627
- Conditions
- Acute Myeloid Leukemia, Azacitidine, Hematologic Diseases, +12 more
- Locations
-
- The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou, Henan, China
Clinical trial condition
Azacitidine
Explore clinical trials studying Azacitidine. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Azacitidine trial results
Not Yet Recruiting
A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diagnosed MDS/AML (≥ 10% Blasts) With TP53 Mutations
NCT07646821
- Conditions
- Alfa-2b, Azacitidine, MDS/AML, +1 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States